Agilent Technologies, Inc.: Form 10-Q for the period ended Apr 30, 2019
Filed with the SEC on May 30, 2019 and accepted by EDGAR at May 30, 2019, 16:08 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-02-01 to 2019-04-30 | $1.24bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2018-11-01 to 2019-04-30 | $2.52bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-02-01 to 2019-04-30 | $569.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2018-11-01 to 2019-04-30 | $1.15bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2019-02-01 to 2019-04-30 | $99.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-11-01 to 2019-04-30 | $201.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-02-01 to 2019-04-30 | $354.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2018-11-01 to 2019-04-30 | $709.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-02-01 to 2019-04-30 | $216.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-11-01 to 2019-04-30 | $466.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-02-01 to 2019-04-30 | $17.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2018-11-01 to 2019-04-30 | $35.0m | us-gaap:InterestExpense |
| Income tax | 3 months2019-02-01 to 2019-04-30 | $36.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-11-01 to 2019-04-30 | −$220.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-02-01 to 2019-04-30 | $182.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-11-01 to 2019-04-30 | $686.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-02-01 to 2019-04-30 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-11-01 to 2019-04-30 | $2.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-02-01 to 2019-04-30 | $0.57 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-11-01 to 2019-04-30 | $2.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-02-01 to 2019-04-30 | 321,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-11-01 to 2019-04-30 | 322,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-11-01 to 2019-04-30 | $465.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-11-01 to 2019-04-30 | $78.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2019-02-01 to 2019-04-30 | $52.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 6 months2018-11-01 to 2019-04-30 | $104.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2018-11-01 to 2019-04-30 | $125.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-04-30 | $2.15bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-04-30 | $3.81bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-04-30 | $9.02bn | us-gaap:Assets |
| Current liabilities | At period end2019-04-30 | $1.12bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-04-30 | $3.90bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-04-30 | $1.80bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2019-04-30 | $5.13bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-19-000010. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.